Search filters

Filters
Clear All

Phase

  • 2
  • 1
  • 1
  • 6
  • 10
  • 1
  • 1
  • 9

Found 10 Viral Infections trials

A listing of Viral Infections medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 HIV Prevention Research Division: Generic Interest Form
18-45 years
All genders
The purpose of this study is to determine if you may be eligible to participate in one of ourcurrent research studies being conducted at the University of Pennsylvania. The purposes ofthese studies are to test different methods that might protect people against viruses thatcause transmittable infections or to develop better …
 A5128: Plan for Obtaining Informed Consent to Use Stored Human Biological Materials (HBM) for Currently Unspecified Analyses
18-99 years
All genders
Some samples (for example, blood, tissue, fluids) taken from you during this or another research study might be useful for research at some later date. This study is being done so that your samples can be stored and used at some later date for research studies, including genetic testing. These …
18-99 years
All genders
Phase 1
Interventional
The research study is being conducted to test an experimental drug, GS-8588, for the treatment and remission of human immunodeficiency virus (HIV) infection. GS-8588 is a special type of protein, called an antibody, that helps the immune system bring your immune cells closer to the cells infected with HIV. Finding …
 HPTN 102/PURPOSE 3
18 years and older
Accepts healthy volunteer
Female
Phase 2
This study will test an experimental drug named Lenacapavir (LEN), also known as Sunlenca® for the prevention of HIV-1 infection. The other HIV and pre-exposure prophylaxis (PrEP) medication included in this study is F/TDF (brand name Truvada®) which contains emtricitabine (F) and tenofovir disoproxil fumarate (TDF). F/TDF is approved for …
 Size and Decay of HIV-1 Reservoirs in Tissues and Cerebrospinal Fluid in Participants on Long-Term Antiretroviral Therapy
18-99 years
All genders
The purpose of this study is to look at where human immunodeficiency virus (HIV) might be “hiding” when standard lab tests show that HIV levels in the blood are very low.
 A Phase 1 Study of IL-15 Superagonist (N-803) and Broadly Neutralizing Antibodies to Induce HIV-1 Control
18-70 years
All genders
Phase 1
This study will investigate whether N-803, a new experimental drug that stimulates the immune system, is safe and tolerable when given alone and in combination with two new experimental drugs that are antibodies (natural proteins that the body makes in response to an infection) to HIV (the virus that causes …
 Rubella-Associated Granulomatous Lesions
18-99 years
All genders
The project will estimate the prevalence of RV-associated cutaneous granulomas in normal adult population over a 15-year period and assess the frequency and intensity of virus shedding by these long-term RV carriers. These results will help ascertain the impact of long-term RV carriers that could influence the maintenance of rubella …
 Technology for Detection of SARS-Cov-2 in HIV-Positive Cancer Patients
99 years and younger
All genders
The main purpose of this study is to try a new type of laboratory test for COVID-19 (also called SARS-CoV-2 or novel coronavirus).  COVID-19 is a new disease, so not enough is known about it yet.  This study hopes to collect more information about who is most as risk from …
 Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers with HIV
18-99 years
All genders
Phase 3
The research study is being conducted to examine the effects of personalized smoking cessation medication treatment in order to help people with HIV/AIDS to quit smoking. During the study, participants will take either varenicline (brand name Chantix®) or use the nicotine patch, and they will receive smoking cessation therapy with …
 ASSESSING THE HIV-1 VIRAL RESERVOIR IN TISSUE SAMPLES
18-99 years
All genders
Normal 0 false false false EN-US X-NONE X-NONE Treating HIV infection with antiretroviral therapy (ART) leads to control of the virus and improvement of the immune system, which is your body natural ability to fight diseases. HIV patients who are well controlled (undetectable HIV by blood tests) still have HIV …